Data-Driven Endocrine Solutions.

Endocrine Technologies develops advanced clinical decision support tools that improve glycemic & metabolic outcomes, enhance patient safety, reduce provider and staff workload across clinical settings.

Optimize your glycemic outcomes with our comprehensive metabolic management platform.

Industry leading performance.

Our leading glycemic management platform, Glucopilot™, uses a patented dosing algorithm that has proven performance.

Maximize Your Time-in-Range

Reference: Unpublished analysis of four-year longitudinal performance data on Glucopilot (n=4500+ patients)

Reach euglycemia in ~3 hours

In a 6-hospital analysis with 5,478 patients, Glucopilot reached target glucose (70–180 mg/dL) in 191 minutes, compared to 222 minutes with the industry standard (p < .001). Reference: Lalani et al. Journal of Diabetes Science and Technology. 2023.

Key Features of Glucopilot

Personalized & Adaptive Formula

•Individualizes insulin infusion rates and adjustments to account for inter- and intra-patient variability in insulin sensitivity, counter-regulatory hormonal responses, comorbidities, and co-medications

•Offers a suite of customizable modules covering clinical scenarios such as DKA/HHS, perioperative glycemic control, TPN/tube feeds, labor & delivery, cardiovascular surgery, trauma, and pediatric care

•Facilitates the management of complex clinical situations such as euglycemic ketoacidosis and hyperkalemia management

Real-Time Alerts & Nudge Technology

•Employs real-time, context-aware alerts / recommendations to aid users in metabolic management decisions

•Supports clinical judgment by offering actionable recommendations while preserving provider autonomy through override capabilities

Epic-Native Integration

•Embedded in EPIC, ensuring continuous functionality with minimal hospital IT intervention

•Streamlined, intuitive interface, with automated data pulls from labs, medications, and nutrition orders to reduce manual entry errors

CMS-Ready eCQM Reporting

•Generates detailed reports on glycemic control metrics aligned with upcoming CMS electronic Clinical Quality Measures (eCQMs) for hyperglycemia management in patients on IV insulin (effective Jan 2026)

•Facilitates institutional QI initiatives by tracking time-in-range and hypoglycemia events at both the patient and population levels

Book a Demo.

Fill out some info and we will be in touch shortly. We can’t wait to hear from you!